课题基金 / 基金详情

Non-Human Primate Models to Evaluate Therapeutic Strats and Topical Microbicides

Non-Human Primate Models to Evaluate Therapeutic Strats and Topical Microbicides
用于评估治疗策略和局部杀菌剂的非人类灵长类动物模型
批准号:
8503542
负责人:
NANCY LIN
金额:
$117.27万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-01 至 2012-12-31

项目摘要

项目成果

NANCY LIN的其他基金

相似基金

相关文献

中文摘要
翻译
本合同的目的是为在SIV/SHIV猕猴动物模型中评估治疗药物/策略和局部杀微生物剂提供资源。用于评估的研究产品将由研究产品的赞助商或通过NIAID提供给承包商。项目主任将选择要进行的研究,包括:
英文摘要
The objective of this contract is to provide a resource to evaluate therapeutic agents/strategies and topical microbicides in SIV/SHIV macaque animal models. Study products for evaluation will be provided to the Contractor by the sponsor of the study product or through the NIAID. The Project Officer will select the studies to be performed, to include: ¿ Confirmation of efficacy of candidates/interventions that have proved promising in other animal models ¿ Proof-of-concept studies with the potential to advance development of an agent or strategy ¿ Evaluations that cannot be done in other animal models of HIV infection ¿ Development of new and improved SIV/SHIV macaque animal models ¿ In vitro assessment of efficacy and toxicity of therapeutic agents and microbicides in non-human primate and human cells
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HIV-1 gp120 PROTEIN
NIAID PRECLINICAL DEVELOPMENT SUPPORT - TOXICITY TESTING FOR CH505 T/F GP120 PROTEIN
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF HCMV-TR3∆PP71 HIVGAG FOR CLINICAL TRIALS
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF MHRP GP145 CLADE C PROTEIN
海外基金